Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ariel@arielbalter.com
    Junior Member
    • May 2017
    • 2

    #1

    Typical costs for RNA-Seq analysis

    This is kind of the wrong place to post this question given that we are all analysts who do the work (mostly at universities) rather than sending it out. But I would like to know what companies that do analysis that is out-sourced generally charge. Consider an experiment such as this--three biological replicates, each with three samples:

    Code:
    | sample | treatment | replicate |
    |--------|-----------|-----------|
    | t1_A   | Tx1       | A         |
    | t2_A   | Tx2       | A         |
    | c_A    | control   | A         |
    | t1_B   | Tx1       | B         |
    | t2_B   | Tx2       | B         |
    | c_B    | control   | B         |
    | t1_C   | Tx1       | C         |
    | t2_C   | Tx2       | C         |
    | c_C    | control   | C         |
    What do you think an investigator would need to pay to outsource standard analysis:

    1. Sample quality
    1. Gene expression per sample
    1. Cross-sample FDR within replicate
    1. Cross-replicate FDR
    1. Pathway analysis
    1. Standard visualizations (MDS, PCA, MA, heatmap, venn)
    Last edited by [email protected]; 05-04-2017, 09:14 AM.
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Here is one option.

    If you are at an academic institution it is very hard to do apple to apple comparisons since most institutions subsidize/discount services/compute time in creative ways so you will not know for sure. But then you are likely looking for a ballpark estimate anyway.

    Comment

    • ariel@arielbalter.com
      Junior Member
      • May 2017
      • 2

      #3
      HA! @GenoMax--that was my post that I made just now and they closed it :-/

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      13 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-13-2026, 09:56 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-09-2026, 11:14 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Working...